4[1]Dai Y, Roman M, Naviaux RK, et al. Gene therapy via primary myoblasts :long term expression of factor Ⅸ protein following transplantation in vivo[J]. Proc Natl Acad Sci USA,1992, 89: 10892-10895.
5[2]Naldini L, Blome V, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector[J]. Science, 1996, 272: 263-267.
6[3]Blaese RM ,Culver KW, Miller AD, et al. T-lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years[J]. Science, 1995,270:475-480.
7[4]Fisher K J, Choi H, Burda J, et al. Recombinant adennovirus delected of all viral genes for gene therapy of cystic fibrosis[J]. Virol, 1996,217: 11-22.
8[5]During MJ , Naegele JR, O' Maller KL, et al. Long-term behavioral recovery in Pakinsonian rats by an HSV vector expressing tyrosine hydroxylase[J]. Science, 1994,266 : 1399-1403.
9[6]Kaplitt MG , Leone P, Samulski RJ, et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain[J]. Nat Genet, 1994,8:148-154.
10[7]Grimm D, Kern A, Rittner K, et al. Novel tools for production and purification of recombinant adenoassociated virus vectors[J]. Hum Gene Ther, 1998,9: 2745-608.
10Roth CM,Sundaram S.Engineering synthetic vectors for improved DNA delivery:insights from intracellular pathways[J].Annu Rev Biomed Eng,2004,6:397426.
